Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Taranto

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cell Death & Disease|January 16, 2026
Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survivalRuchi Kudalkar, Johnathan Altom, Joshua Galloway, et al.
International Journal of Molecular Sciences|January 8, 2020
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe DiseaseMirella Belleri, Daniela Coltrini, Marco Righi, et al.
Haematologica|December 19, 2025
NEAT1: a multifaceted long non-coding RNA in multiple myelomaGabriele Benini, Sara Taranto, Margherita Sciumè, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 1, 2024
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myelomaArianna Giacomini, Sara Taranto, Giorgia Gazzaroli, et al.
Cancers|June 2, 2021
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma CellsRoberto Ronca, Sara Taranto, Michela Corsini, et al.
International Journal of Molecular Sciences|December 15, 2020
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative StressArianna Giacomini, Sara Taranto, Sara Rezzola, et al.
Cancer Letters|December 3, 2021
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancerPaola Chiodelli, Daniela Coltrini, Marta Turati, et al.
Cancers|September 5, 2019
Long Pentraxin-3 Follows and Modulates Bladder Cancer ProgressionSara Matarazzo, Laura Melocchi, Sara Rezzola, et al.
European Journal of Medicinal Chemistry|May 18, 2021
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myelomaRiccardo Castelli, Sara Taranto, Lucia Furiassi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinomaSara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell Death & Disease|January 16, 2026
Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survivalRuchi Kudalkar, Johnathan Altom, Joshua Galloway, et al.
International Journal of Molecular Sciences|January 8, 2020
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe DiseaseMirella Belleri, Daniela Coltrini, Marco Righi, et al.
Haematologica|December 19, 2025
NEAT1: a multifaceted long non-coding RNA in multiple myelomaGabriele Benini, Sara Taranto, Margherita Sciumè, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 1, 2024
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myelomaArianna Giacomini, Sara Taranto, Giorgia Gazzaroli, et al.
Cancers|June 2, 2021
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma CellsRoberto Ronca, Sara Taranto, Michela Corsini, et al.
International Journal of Molecular Sciences|December 15, 2020
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative StressArianna Giacomini, Sara Taranto, Sara Rezzola, et al.
Cancer Letters|December 3, 2021
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancerPaola Chiodelli, Daniela Coltrini, Marta Turati, et al.
Cancers|September 5, 2019
Long Pentraxin-3 Follows and Modulates Bladder Cancer ProgressionSara Matarazzo, Laura Melocchi, Sara Rezzola, et al.
European Journal of Medicinal Chemistry|May 18, 2021
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myelomaRiccardo Castelli, Sara Taranto, Lucia Furiassi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinomaSara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Pageof 2